Duo Wang

机构：University of Occupational and Environmental Health Japan, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Clinical Laboratories, University of Chinese Academy of Sciences · ORCID：0009-0000-5802-9226

发表论文 34 篇 · 总被引 431 次 · h-index 11

代表论文

• Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives (2023 · Materials Today Bio · 被引 84)
• Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial–mesenchymal transition during radiation-induced pulmonary fibrosis (2022 · Respiratory Research · 被引 36)
• Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma (2024 · Frontiers in Immunology · 被引 28)
• Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma (2023 · Frontiers in Immunology · 被引 27)
• A real-world multi-center RNA-seq benchmarking study using the Quartet and MAQC reference materials (2024 · Nature Communications · 被引 23)
• Integrated Bioinformatics Analysis for the Screening of Hub Genes andTherapeutic Drugs in Hepatocellular Carcinoma (2022 · Current Pharmaceutical Biotechnology · 被引 20)